Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Gene expression profiling in Nalm6 ALL leukemia cells

ABSTRACT: Identify the expression intensity for all genes in Nalm6 cells and all the genes are divided into 4 equal groups with group 1 containing the 25% of genes that were expressed at the highest levels, and group 4 containing the 25% of genes that were expressed at the lowest levels.

ORGANISM(S): Homo sapiens

PROVIDER: GSE44214 | GEO | 2015/11/03

SECONDARY ACCESSION(S): PRJNA189194

REPOSITORIES: GEO

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
		Other

Items per page:

1 - 1 of 1

Similar Datasets

Gene expression profiling in Nalm6 ALL leukemia cells

Project description:Identify the expression intensity for all genes in Nalm6 cells and all the genes are divided into 4 equal groups with group 1 containing the 25% of genes that were expressed at the highest levels, and group 4 containing the 25% of genes that were expressed at the lowest levels. Total RNA are isolated from 3 lots of Nalm6 cells and gene expression are determined by microarray gene expression analysis with Nimblegen Human 385K array.

2015-11-03 | E-GEOD-44214 | biostudies-arrayexpress

PAX5 CHIP-seq in NALM6 cell line

Project description:CHIP-seq performed with no drug treatment in NALM6 cells

2020-01-23 | GSE115764 | GEO

Comprehensive analysis of molecular expression differences in NALM6 cells before and after use of verteporfin

Project description:Aims:This study used cell line models and patient datasets to investigate the role of YAP1 in B- ALL. Methods: We used RNA-Seq to compare the gene expression levels of the Hippo pathway-related molecules before and after verteporfin (VP) treatment to identify important Hippo pathway-related genes in the NALM6 cell line. Results:we identified a total of 2002 differentially expressed genes in VP and DMSO treatment groups (FC ≥ 1.5, p ≤ 0.05), including 1042 upregulated and 960 downregulated genes, of which 146 were associated with the Hippo signaling pathway. Further screening resulted in 29 identified genes comprising 12 upregulated and 17 downregulated genes, which were associated with VP-treated NALM6 cells. Conclusion:Pre- and post-VP treatment, the upstream gene LATS1 was upregulated, and its overexpression increased YAP1 Ser127 site phosphorylation further studies.

2024-11-01 | GSE231947 | GEO

Response to dexamethasone in A549, U2OS, and Nalm6

Project description:Transcriptional profiling of A549, U2OS, and Nalm6 comparing dexamethason with vehicle control, 3 hour timepoint

2012-07-31 | GSE38971 | GEO

Response to dexamethasone in A549, U2OS, and Nalm6

Project description:Transcriptional profiling of A549, U2OS, and Nalm6 comparing dexamethason with vehicle control, 3 hour timepoint Two conditions (treated and untreated), three cell types. Biological replicates: 3 treated and 3 vehicle controls for each cell type. Each array is a two-color hyb of treated vs control in a single cell type (9 arrays total). One dye swap for each condition

2012-07-30 | E-GEOD-38971 | biostudies-arrayexpress

PAX5 CHIP-seq in NALM6 cell line

Project description:PAX5 CHIP-seq in NALM6 cell line

| PRJNA475974 | ENA

Histone H3, lysine 27 acetylation ChIP-seq in NALM6 expressing ETV6-RUNX1

Project description:ETV6-RUNX1 is a fusion protein bringing together almost the entire coding sequence of RUNX1, including the DNA binding runt domain, and the N-terminus of ETV6 which is known to include transcriptional repressors including histone deacetylation 3 (HDAC3). Here we perform ChIP-seq for the active chromatin mark H3K27ac in the NALM6 B-cell acute lymphoblastic leukaemia cell line expressing ETV6-RUNX1 or mutant derivatives of ETV6-RUNX1: Delta helix-loop-helix (dHLH) is a deletion of the pointed domain; R139G is a point mutation in the runt DNA-binding domain.

2022-10-31 | E-MTAB-12207 | biostudies-arrayexpress

Effect of HS-mediated telomere disruption on Nalm6 cells

Project description:Nalm6 tumour cells were engineered with focused ultrasound (FUS)-controllable CRISPR (heat-inducible CRISPR) with telomere-targeting gRNA or control non-targeting (NT) gRNA, and either treated with heat shock (HS) or no HS (control, CT). We observed that a relatively short duration of HS (10 min) significantly inhibited the proliferation of the cells engineered with telomere FUS-CRISPR, but not that of the cells with NT FUS-CRISPR, suggesting that telomere disruption rather than hyperthermia itself suppressed cell growth. Bulk RNA-seq further revealed that FUS-CRISPR-mediated telomere disruption led to the upregulation of multiple genes associated with the stress response p53 signaling pathway and apoptotic process and the TNF family in the engineered cells to trigger cell cycle arrest.

2024-10-14 | GSE279445 | GEO

Effect of HS-mediated telomere disruption on Nalm6 cells

Project description:Effect of HS-mediated telomere disruption on Nalm6 cells

| PRJNA1172720 | ENA

Nalm 6 WT Nalm6 BKO Nalm 6 A hets

Project description:Nalm 6 WT Nalm6 BKO Nalm 6 A hets

| PRJNA623327 | ENA